CimCure Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.3M

  • Investors
  • 6

CimCure General Information

Description

Developer of cancer immunotherapy designed for the treatment of solid tumors. The company has developed cancer vaccines using its proprietary technology of targeted conjugate vaccines and identified specific targets in the tumor vasculature, which directly target and destroy endothelial cells in the tumor, enabling physicians to treat cancer effectively by preventing tumor growth.

Contact Information

Website
www.cimcure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Plesmanlaan 125
  • 1066 CX Amsterdam
  • Netherlands
+31 06
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Plesmanlaan 125
  • 1066 CX Amsterdam
  • Netherlands
+31 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CimCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 07-Jun-2022 $5.3M Completed Clinical Trials - Phase 2
5. Later Stage VC Completed Clinical Trials - Phase 2
4. Grant 01-May-2020 Completed Clinical Trials - Phase 2
3. Seed Round 01-Mar-2020 Completed Clinical Trials - Phase 2
2. Grant 01-Mar-2019 $312K Completed Startup
1. Grant 01-Nov-2017 $117K Completed Startup
To view CimCure’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CimCure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CimCure Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Positron Ventures Venture Capital Minority
Angel (individual) Minority
Pharma Tide Invest Venture Capital Minority
Health ~ Holland Government
Government of the Netherlands Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

CimCure FAQs

  • When was CimCure founded?

    CimCure was founded in 2015.

  • Where is CimCure headquartered?

    CimCure is headquartered in Amsterdam, Netherlands.

  • What is the size of CimCure?

    CimCure has 10 total employees.

  • What industry is CimCure in?

    CimCure’s primary industry is Drug Discovery.

  • Is CimCure a private or public company?

    CimCure is a Private company.

  • What is CimCure’s current revenue?

    The current revenue for CimCure is .

  • How much funding has CimCure raised over time?

    CimCure has raised $5.3M.

  • Who are CimCure’s investors?

    Positron Ventures, , Pharma Tide Invest, Health ~ Holland, and Government of the Netherlands are 5 of 6 investors who have invested in CimCure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process